Tag archive for ‘Medidur’
pSivida: One Step Away from Upgrading the Stock (PSDV, Hold, $2.80))
Investment Overview pSivida holds a unique, leading position in developing inserts that provide long acting delivery of drugs to the retina in the back of the eye. Eye drops cannot deliver drugs effectively to the retina and systemic therapy requires large doses of drug to be delivered in order to allow some small part of […]